Home/Filings/4/0001437749-21-017452
4//SEC Filing

Miller Langdon L 4

Accession 0001437749-21-017452

CIK 0001318641other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 4:22 PM ET

Size

6.1 KB

Accession

0001437749-21-017452

Insider Transaction Report

Form 4
Period: 2021-07-22
Miller Langdon L
President & CMO
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-07-2210,0000 total
    Exercise: $3.00From: 2016-05-04Exp: 2021-08-09Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.005 per share

    2021-07-22$3.00/sh+10,000$30,00010,000 total

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001641593

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:22 PM ET
Size
6.1 KB